COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
Authors:
- Igor PetkovićIPIgor Petković
- Johannes BischofJBJohannes Bischof
- Thomas KocherTKThomas Kocher
- Oliver Patrick MarchOMOliver Patrick March
- Bernadette LiembergerBLBernadette Liemberger
- Stefan HainzlSHStefan Hainzl
- Dirk StrunkDSDirk Strunk
- Julia ReicheltJRJulia Reichelt
- Christina Guttmann-GruberCGChristina Guttmann-Gruber
- Verena WallyVWVerena Wally
Open Access
- 25 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 976604
Abstract
Background: Epidermolysis bullosa (EB), a severe genetic disorder characterized by blister formation in skin, is caused by mutations in genes encoding dermal-epidermal junction proteins that function to hold the skin layers together. CRISPR/Cas9-induced homology-directed repair (HDR) represents a promising tool for editing causal mutations in COL17A1 in the treatment of junctional epidermolysis bullosa (JEB).Methods: In this study, we treated primary type XVII collagen (C17)-deficient JEB keratinocytes with either Cas9 nuclease or nickase (Cas9n) ribonucleoproteins (RNP) and a single-stranded oligonucleotide (ssODN) HDR template in order to correct a causal pathogenic frameshift mutation within the COL17A1 gene.Results: As analyzed by next-generation sequencing of RNP-nucleofected keratinocytes, we observed an HDR efficiency of ∼38% when cells were treated with the high-fidelity Cas9 nuclease, a mutation-specific sgRNA, and an ssODN template. The combined induction of end-joining repair and HDR-mediated pathways resulted in a C17 restoration efficiency of up to 60% as assessed by flow cytometry. Furthermore, corrected JEB keratinocytes showed a significantly increased adhesive strength to laminin-332 and an accurate deposition of C17 along the basement membrane zone (BMZ) upon differentiation into skin equivalents.Conclusion: Here we present a gene editing approach capable of reducing end joining-generated repair products while increasing the level of seamless HDR-mediated gene repair outcomes, thereby providing a promising CRISPR/Cas9-based gene editing approach for JEB.Keywords
Funding Information
- Austrian Science Fund (P 32769-B)
- Paracelsus Medizinische Privatuniversität (A-20/02/041-KOU)
This publication has 26 references indexed in Scilit:
- COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis BullosaMolecular Therapy, 2017
- Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex PatientsMolecular Therapy - Methods & Clinical Development, 2017
- Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem CellsJournal of Investigative Dermatology, 2017
- Cas-analyzer: an online tool for assessing genome editing results using NGS dataBioinformatics, 2016
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavageNature, 2016
- Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?Trends in Biochemical Sciences, 2015
- NIH Image to ImageJ: 25 years of image analysisNature Methods, 2012
- Dynamic Interactions of Epidermal Collagen XVII with the Extracellular MatrixThe American Journal of Pathology, 2011
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cellsNature Medicine, 2006
- Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapyClinical and Experimental Dermatology, 2003